Artisan International Explorer Fund's top three contributors in Q1 were IQE, Impro and Vitzrocell and top three detractors ...
7h
Protara Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update
The Company intends to submit a Biologics License Application (BLA) for TARA-002 in Lymphatic Malformations (LMs) in 2H 2027Hosting virtual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results